Back
Fulcrum Therapeutics Vs. Ingevity Industry Stock Comparison
Sell
19
FULC
Fulcrum Therapeutics
Last Price:
3.81
Seasonality Move:
37.25%
Sell
1
NGVT
Ingevity
Last Price:
37.03
Seasonality Move:
10.62%
Sell
19
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.67. The Score for FULC is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Ingevity (NGVT)
is a Sell
Is Ingevity a Buy, Sell or Hold?
- The current Ingevity [NGVT] share price is $33.06. The Score for NGVT is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGVT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.
FULC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.1 | Sell |
| Relative Strength Index (14 RSI): | 33.74 | Sell |
| Chaikin Money Flow: | -476921 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NGVT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 34.38 | Sell |
| Chaikin Money Flow: | -258474 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
FULC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.64 | Buy |
| 20-day SMA: | 4.52 | Sell |
| 50-day SMA: | 7.16 | Sell |
| 200-day SMA: | 7.82 | Sell |
| 8-day EMA: | 3.74 | Sell |
| 20-day EMA: | 4.61 | Sell |
| 50-day EMA: | 6.16 | Sell |
| 200-day EMA: | 7.08 | Sell |
NGVT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.45 | Sell |
| 20-day SMA: | 37.7 | Sell |
| 50-day SMA: | 38.26 | Sell |
| 200-day SMA: | 44.33 | Sell |
| 8-day EMA: | 37.5 | Sell |
| 20-day EMA: | 38.02 | Sell |
| 50-day EMA: | 39.02 | Sell |
| 200-day EMA: | 43.99 | Sell |
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.79 per share.
Ingevity Earnings Growth & NGVT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.69 per share, and an increase next year of $1.18 per share.
Fulcrum Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ingevity Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||